Notificación FACEDRA basada en FHIR® R5 | - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Tipo de Sospecha

Page standards status: Informative

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "suspect-type",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem suspect-type</b></p><a name=\"suspect-type\"> </a><a name=\"hcsuspect-type\"> </a><p>This case-sensitive code system <code>https://hl7.comisca.org/fhir/CodeSystem/suspect-type</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">suspected<a name=\"suspect-type-suspected\"> </a></td><td>Sospechoso</td><td>Medicamento considerado el agente causal principal del evento adverso.</td></tr><tr><td style=\"white-space:nowrap\">concomitant<a name=\"suspect-type-concomitant\"> </a></td><td>Concomitante</td><td>Medicamento administrado de forma simultanea sin causalidad directa identificada.</td></tr><tr><td style=\"white-space:nowrap\">interacting<a name=\"suspect-type-interacting\"> </a></td><td>Interaccion</td><td>Medicamento cuya interaccion pudo contribuir al evento adverso.</td></tr></table></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "cgp"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode" : "informative",
      "_valueCode" : {
        "extension" : [
          {
            "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical" : "https://hl7.comisca.org/fhir/ImplementationGuide/hl7.fhir.uv.facedra"
          }
        ]
      }
    }
  ],
  "url" : "https://hl7.comisca.org/fhir/CodeSystem/suspect-type",
  "version" : "0.1.1",
  "name" : "SuspectType",
  "title" : "Tipo de Sospecha",
  "status" : "active",
  "experimental" : true,
  "date" : "2026-05-18T14:13:47-06:00",
  "publisher" : "SICA COMISCA",
  "contact" : [
    {
      "name" : "SICA COMISCA",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://comisca.org/facedra/fhir"
        },
        {
          "system" : "email",
          "value" : "notifacedra@comisca.org"
        }
      ]
    },
    {
      "name" : "Notificación FACEDRA basada en FHIR® R5",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://hl7.comisca.org/fhir"
        },
        {
          "system" : "email",
          "value" : "notifacedra@comisca.org"
        }
      ]
    }
  ],
  "description" : "Catalogo FACEDRA para clasificar la relacion de un medicamento con el evento adverso reportado.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "001"
        }
      ]
    }
  ],
  "copyright" : "Derechos de autor (c) 2026, Consejo de Ministros de Salud de Centroamérica y República Dominicana (COMISCA). Este trabajo se distribuye bajo la licencia CC0-1.0, lo que permite su uso sin restricciones, incluso para fines comerciales. HL7®, FHIR® y el logotipo FHIR (diseño de llama) son marcas registradas de Health Level Seven International. Su uso no implica respaldo por parte de HL7. El contenido normativo de FHIR es © HL7.org 2011+. Todos los derechos reservados.",
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 3,
  "concept" : [
    {
      "code" : "suspected",
      "display" : "Sospechoso",
      "definition" : "Medicamento considerado el agente causal principal del evento adverso."
    },
    {
      "code" : "concomitant",
      "display" : "Concomitante",
      "definition" : "Medicamento administrado de forma simultanea sin causalidad directa identificada."
    },
    {
      "code" : "interacting",
      "display" : "Interaccion",
      "definition" : "Medicamento cuya interaccion pudo contribuir al evento adverso."
    }
  ]
}